News

7 Sep 2023 Ibex Launches Galen™ Breast HER2, Supporting Improved Biomarker Scoring in Breast Cancer Patients

Read more

6 Sep 2023 Ibex Raises $55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis

Read more

9 Mar 2023 Ibex and Alverno Laboratories sign multi-year, multi-tissue expansion agreement of AI for cancer diagnosis

Read more

7 Mar 2023 Ibex secures PathLAKE contracts to roll out AI-based cancer diagnostics to UK hospitals

Read more

6 Mar 2023 Ibex scoops second win of the UK Artificial Intelligence Award with leading NHS trusts

Read more

9 Feb 2023 Ibex’s Galen™ Prostate becomes first standalone AI-powered cancer diagnostics solution to obtain CE mark under the IVDR

Read more

24 Jan 2023 Ibex Medical Analytics Enters Collaboration with AstraZeneca and Daiichi Sankyo to Develop AI-based HER2 Scoring Product

Read more
Excellent Outcomes of Ibex’s AI Solution for Breast Cancer Detection

21 Dec 2022 Institut Curie study published in a Nature Journal reporting excellent outcomes of Ibex’s AI solution for breast cancer detection

Read more

14 Dec 2022 Ibex deploys AI-powered cancer diagnostics solution at UPMC

Read more

7 Dec 2022 Leading UK diagnostics provider source LDPath expands AI capabilities with Ibex Medical Analytics

Read more

4 Sep 2022 Ibex announces Galen™ 3.0, a transformative cancer diagnostics platform offering new detection capabilities and a broad feature set

Read more

2 Sep 2022 Ibex and Medipath sign multi-year, multi-site and multi-tissue expansion of AI for cancer diagnosis across France

Read more